Robeco Institutional Asset Management B.V. Immunocore Holdings PLC Transaction History
Robeco Institutional Asset Management B.V.
- $46 Billion
- Q2 2024
A detailed history of Robeco Institutional Asset Management B.V. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 19,869 shares of IMCR stock, worth $623,886. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,869
Previous 72,841
72.72%
Holding current value
$623,886
Previous $4.73 Million
85.78%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding IMCR
# of Institutions
150Shares Held
39.8MCall Options Held
157KPut Options Held
135K-
Wellington Management Group LLP Boston, MA6.38MShares$200 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$153 Million2.76% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.99MShares$94 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$88.9 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA1.95MShares$61.3 Million0.05% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.38B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...